These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34839416)

  • 21. Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients.
    Tanaka T; Otani K; Egashira R; Kashima Y; Taniguchi H; Kondoh Y; Kataoka K; Shiraki A; Kitasato Y; Leslie KO; Fukuoka J
    Respir Med; 2012 Dec; 106(12):1765-70. PubMed ID: 22992339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a radiomics nomogram to predict the treatment resistance of Chinese MPO-AAV patients with lung involvement: a two-center study.
    Chen J; Meng T; Xu J; Ooi JD; Eggenhuizen PJ; Liu W; Li F; Wu X; Sun J; Zhang H; Zhou YO; Luo H; Xiao X; Pei Y; Li W; Zhong Y
    Front Immunol; 2023; 14():1084299. PubMed ID: 37503353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and outcomes of small airway disease in ANCA-associated vasculitis.
    Zhou P; Gao L; Li Z; Que C; Li H; Ma J; Wang G
    Respirology; 2024 Feb; 29(2):146-157. PubMed ID: 37857408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary isomorphic red blood cells for the prediction of disease severity and renal outcomes in MPO-ANCA-associated vasculitis: a retrospective cohort study.
    Wang F; Jin Y; Zhou F; Luo L; Tang J; Huang L; Hu X; Liao Z; Jiang Y; Dengshuang L; Ge H; Sun D; Xiao G; Feng J; Li X
    J Nephrol; 2023 Nov; 36(8):2295-2304. PubMed ID: 37395920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients' Outcomes.
    Sun K; Fisher JH; Pagnoux C
    Curr Rheumatol Rep; 2022 Aug; 24(8):259-267. PubMed ID: 35794350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis.
    Wu T; Zhang Y; Cen Z; Ying Y; Sun C; Lv C; Ding Q
    Ther Adv Respir Dis; 2022; 16():17534666221140974. PubMed ID: 36484348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchiectasis in patients with antineutrophil cytoplasmic antibody-associated vasculitis: a case control study on clinical features and prognosis.
    Ren J; Ding Y; Zhao J; Sun Y
    Expert Rev Respir Med; 2022 Jun; 16(6):697-705. PubMed ID: 35687867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid disease in ANCA-associated vasculitis: a clinical and epidemiological study.
    Wilding A; Smith R; Jayne D; Segelmark M; Mohammad AJ
    RMD Open; 2024 Apr; 10(2):. PubMed ID: 38688691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-neutrophil cytoplasmic antibody patterns can predict clinical relapse in ANCA-associated vasculitis: overall population and subgroups.
    Jiang C; Liu J; Wang H; Liu H; Fu Z; Li M; Liu X
    Clin Exp Rheumatol; 2023 Apr; 41(4):848-855. PubMed ID: 36533974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and outcomes of MPO-ANCA-associated glomerulonephritis with bronchiectasis: A retrospective case-control study.
    Luo L; Li H; Tang J; Liao Z; Wang F; Jin Y; Zhou F; Feng J; Li X
    Semin Arthritis Rheum; 2022 Dec; 57():152082. PubMed ID: 36058136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
    Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
    J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microparticles Expressing Myeloperoxidase and Complement C3a and C5a as Markers of Renal Involvement in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Antovic A; Mobarrez F; Manojlovic M; Soutari N; De Porta Baggemar V; Nordin A; Bruchfeld A; Vojinovic J; Gunnarsson I
    J Rheumatol; 2020 May; 47(5):714-721. PubMed ID: 31371653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex disparities in clinicopathological features and outcomes of patients with myeloperoxidase-ANCA-associated vasculitis: a retrospective study of 366 cases in a single Chinese center.
    Meng T; Zhu P; Shen C; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Chen JB; Lin W; Xiong Q; Gong Y; Tang R; Ao X; Peng W; Xiao Z; Xiao P; Xiao X; Zhong Y
    Clin Exp Med; 2023 Nov; 23(7):3565-3572. PubMed ID: 37428262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High levels of platelet
    Huang L; Shen C; Zhong Y; Ooi JD; Eggenhuizen PJ; Zhou Y; Chen J; Wu T; Meng T; Xiao Z; Lin W; Tang R; Ao X; Xiao X; Zhou Q; Xiao P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):211-218. PubMed ID: 35545411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis].
    Zhou XL; Zheng MJ; Shuai ZW; Zhang L; Zhang MM; Chen SY
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):427-432. PubMed ID: 28592042
    [No Abstract]   [Full Text] [Related]  

  • 36. Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients.
    Yamaguchi K; Yamaguchi A; Itai M; Onuki Y; Shin Y; Uno S; Hanazato C; Taguchi K; Umetsu K; Aikawa M; Kouno S; Takemura M; Hara K; Motegi S; Tsukida M; Ota F; Tsukada Y; Motegi M; Nakasatomi M; Sakairi T; Ikeuchi H; Kaneko Y; Hiromura K; Maeno T
    Rheumatol Int; 2021 Sep; 41(9):1641-1650. PubMed ID: 34056682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the risk factors for end‑stage renal disease and mortality in ANCA-associated vasculitis: a study from a single center of the Chinese Rheumatism Data Center.
    Guo Q; Yu L; Zhang X; Shang J; Duan X
    Clin Rheumatol; 2023 Feb; 42(2):489-499. PubMed ID: 36367596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Oncomarkers in Patients with MPO-ANCA-Positive Vasculitis: Diagnostic and Prognostic Predictive Values for Interstitial Lung Disease.
    Yang S; Zhan X; Wang J; Fan Y; Ma R; Ye Q
    Lung; 2022 Jun; 200(3):331-338. PubMed ID: 35426513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.